Sep 1, 2022· Comment from Association for Accessible Medicines (AAM)· FDA-2017-D-1956-0031
FDA, Please find attached comments from the Association for Accessible Medicines regarding Docket FDA-2017-D-1956-0026 regarding FDA's Draft Guidance, "Identifying Trading Partners Under the Drug Supply Chain Security Act." Thanks, Scott Kuzner Senior Director, Sciences and Regulatory Affairs Association for Accessible Medicines